Aligos Therapeutics (ALGS) Operating Margin Growth (1y) (2022 - 2026)
Aligos Therapeutics (ALGS) Operating Margin Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.35 Bn | 131.49 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.24 Bn | 78.25 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.83 Bn | 53.69 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.95 Bn | 9.56 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.50 Bn | 26.34 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.44 Bn | - | -1,651.00 |
| 10 | Aligos Therapeutics | 69.89 Mn | 39.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 523,591.00 |
| Dec 31, 2025 | -1.37 Mn |
| Jun 30, 2025 | 56,550.00 |
| Mar 31, 2025 | -301,080.00 |
| Dec 31, 2024 | -151,458.00 |
| Sep 30, 2024 | 14,722.00 |
| Jun 30, 2024 | -204,378.00 |
| Mar 31, 2024 | 1.39 Mn |
| Dec 31, 2023 | 244,754.00 |
| Sep 30, 2023 | -129,622.00 |
| Mar 31, 2023 | -1.57 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 168,999.00 |
| Mar 31, 2022 | 166,535.00 |